This is a clinical trial (study), to be conducted at multiple clinical sites, of an oral study drug (EP262) that will be investigated in adult participants with Chronic Inducible Urticaria (CIndU) to assess if it is safe and improves reactions to known CIndU triggers.

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-504800-28-00

Acronym

EP-262-102

Enrollment

Registered

2023-12-04

Start date

2024-02-23

Completion date

2024-10-22

Last updated

2024-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Inducible Urticaria

None listed

Sex/Gender

All

Age

18 Years to No maximum

Germany, Netherlands, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026